BUB856Date
Fund Management Services
SFC Type 9 Licensed — Professional Asset Management for Institutions and HNWIs
Professional Asset Management Platform
SKYW holds a Hong Kong Securities and Futures Commission Type 9 (Asset Management) license, enabling compliant management of client assets. Leveraging the resources and research capabilities of our three institutional shareholders, we offer multi-strategy portfolios spanning HK equities, A+H shares, and cross-border alternative assets.
Clients include sovereign funds, family offices, corporate pension funds, and qualified overseas institutional investors. Fund structures are customized to client tax and compliance requirements, with flexible setup via Hong Kong OFC, Cayman funds, or Singapore VCC.
Core Strategies
01
Multi-Strategy Investing
HK new economy, A+H dual-listing arbitrage, alternative assets and cross-border thematic portfolios
02
Customized Structures
HK OFC / Cayman / Singapore VCC — matched to optimal compliance structure per client needs
03
Institutional Compliance
PwC audit, Fireblocks custody, meeting SFC and international institutional standards
04
Investor Reporting
Full look-through periodic reporting and NAV calculation services
HONG KONG OFC · EMINENCE
Hong Kong Platform · Ten Sub-Funds
Eminence Global Master Fund OFC · BUB855
BWH893Date
Eminence Global M&A Fund
BWH894Date
Eminence Global Trade Development Fund
BWH895Date
Eminence Digital Technology Fund
BWH896Date
Eminence Greater Bay Area Technology Innovation Fund
BYE015Date
Eminence Global Gold Fund
BYE016Date
Eminence HK Anchor Fund
BYE017Date
Eminence Global Innovation Fund
BYE018Date
Eminence Pioneer Fund
BYE019Date
Eminence Strategic Capital Fund
Names, identifiers and dates follow the directory supplied by the company; official names remain in English. Theme links are for navigation only and do not confirm mandates, holdings or subscription availability. Investment scope, risks and eligibility are governed by definitive fund documents. Listing here is not a public offer or regulatory endorsement.
SKYW
Pre-IPO Investments
Pre-IPO investment focus
Explore projects within SKYW’s Pre-IPO focus: their businesses, capabilities and development priorities. Select a project for its full profile.
— · — · — · —
Life sciences · Gene therapy
BIOSEN
Introducing BIOSEN: a life sciences platform connecting p53 gene therapy research, viral vector manufacturing and global collaboration.
Explore BIOSENArtificial intelligence · Foundation models
Moonshot AIKimi
A closer look at Moonshot AI and Kimi: foundation model research, agentic applications and a developer ecosystem, viewed through a long-term investment lens.
Explore the Kimi profilePre-IPO is an investment theme, not confirmation of a listing application, timetable, fund holding, allocation or official partnership. These profiles are not investment offers or return commitments.